Loading clinical trials...
Loading clinical trials...
Significant left main (LM) stenosis is associated with a poor prognosis, therefore, adequate judgement of the prognostic significance of LM stenosis is essential to improve patients' prognosis. Recent...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
NCT06535568 · Coronary Disease, Heart Diseases, and more
NCT05846893 · Coronary Artery Disease, Myocardial Ischemia, and more
NCT06420505 · Artery Coronary Stenosis
NCT04014140 · Ischaemic Heart Disease, Coronary Artery Disease, and more
NCT04951050 · Coronary Artery Disease, Coronary Stenosis
Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand
Institute Mutualiste Montsouris
Paris
Centre Cardiologique du Nord
Saint-Denis
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions